ARIA Stock News 6.77 05/13/2014 12:49:57 Ariad Pharmaceuticals

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Ariad Pharmaceuticals (ARIA) 6.77 $ARIA

Investors are Betting Against Ariad Pharmaceuticals (ARIA), Should You? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - 1 hr 59 mins ago
Investors are Betting Against Ariad Pharmaceuticals (ARIA), Should You?

Wider-than-Expected Q1 Loss at MannKind - Analyst Blog
Zacks Equity Research - Zacks Investment Research - 2 hrs 39 mins ago
MannKind's (MNKD) loss of 14 cents per share in the first quarter of 2014 was wider than the Zacks Consensus Estimate by a penny.

Tesaro, Inc. (TSRO) Looks Strong as Stock Rallies 21% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue May 13, 7:44AM CDT
Tesaro, Inc. (TSRO) was a big mover last session, as its shares surge 21% on the day.

ARIAD to Present at UBS Global Healthcare Conference
Business Wire - Tue May 13, 6:35AM CDT
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will present at the UBS Global Healthcare Conference being held in New York City. Harvey J. Berger, M.D., chairman and chief executive officer, will provide an overview of the Company's business on Tuesday, May 20, 2014, at 4:00 p.m. (ET).

84.9% Return Seen to Date on SmarTrend Ariad Pharmaceuticals Call (ARIA)
Comtex SmarTrend(R) - Mon May 12, 12:12PM CDT
SmarTrend identified an Uptrend for Ariad Pharmaceuticals (NASDAQ:ARIA) on November 22nd, 2013 at $3.67. In approximately 6 months, Ariad Pharmaceuticals has returned 84.88% as of today's recent price of $6.79.

Ariad Pharmaceuticals, Inc Earnings: Cloudy Future Drains Enthusiasm
Leo Sun, The Motley Fool - Motley Fool - Mon May 12, 9:20AM CDT
Shares of Ariad Pharmaceuticals fell nearly 5% on May 7 after the company reported its first-quarter earnings. The stock has fallen more than 60% over the past 12 months due to safety concerns about its only...

PharmAthene (PIP) Catches Eye: Stock Rises 6.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon May 12, 8:46AM CDT
PharmAthene (PIP) was a big mover last session, as the company saw its shares rise over 6% on the day.

Corcept Therapeutics (CORT) in Focus: Stock Rises 5.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon May 12, 8:39AM CDT
Corcept Therapeutics Incorporated (CORT) was a big mover last session, as its shares rose almost 6% on the day.

Spectrum Pharma Up on Q1 Earnings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon May 12, 8:00AM CDT
Spectrum Pharma's (SPPI) first quarter 2014 earnings of a penny per share were flat year over year.

NPS Pharmaceuticals (NPSP) Jumps: Stock Up 13.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon May 12, 7:51AM CDT
NPS Pharmaceuticals, Inc. (NPSP) was a big mover last session, as its shares rose almost 14% on the day.

ARIAD's Q1 Loss Narrows - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu May 08, 11:00AM CDT
ARIAD Pharmaceuticals Inc. (ARIA) reported narrower-than-expected loss in the first quarter of 2014.

Wider-than-Expected Q1 Loss at Nektar - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu May 08, 10:20AM CDT
Nektar (NKTR) reported a loss of 37 cents per share in the first quarter of 2014, wider than the Zacks Consensus Estimate of a loss of 35 cents.

Allergan Beats on Earnings, Guidance Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed May 07, 12:50PM CDT
Allergan, Inc. (AGN) reported first quarter 2014 earnings of $1.18 per share.

Ariad Pharmaceuticals' Loss Shrinks 23% as Iclusig Revenue Rises
Sean Williams, The Motley Fool - Motley Fool - Wed May 07, 11:31AM CDT
Controversial small-cap biopharmaceutical company Ariad Pharmaceuticals took steps in the right direction to rebuilding its Iclusig brand this morning with the release of its first-quarter earnings results . For the quarter, total revenue...

Ariad Pharmaceuticals (ARIA) Stock Falls Despite Revenue Beat
at The Street - Wed May 07, 9:51AM CDT
Ariad Pharmaceuticals (ARIA) fell Wednesday despite the company's first-quarter results that beat analysts' expectations.

Today’s Top Biotech Stories: Aegerion, GW, and Ariad Pharmaceuticals
Leo Sun, The Motley Fool - Motley Fool - Wed May 07, 8:11AM CDT
Let's take a closer look at three stocks -- Aegerion Pharmaceuticals , GW Pharmaceuticals , and Ariad Pharmaceuticals -- which could make waves across the health care sector this Wednesday morning. Aegerion slumps on weak earnings...

ARIAD Reports First Quarter 2014 Financial Results and Development Progress
Business Wire - Wed May 07, 6:35AM CDT
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today reported financial results for the first quarter of 2014, including revenue from sales of Iclusig(R) (ponatinib) and licensing agreements. The Company also provided an update on corporate developments.

Look for Shares of Ariad Pharmaceuticals to Potentially Pullback after Yesterday's 5.53% Rise
Comtex SmarTrend(R) - Mon May 05, 4:57PM CDT
Ariad Pharmaceuticals (NASDAQ:ARIA) traded in a range yesterday that spanned from a low of $7.26 to a high of $7.73. Yesterday, the shares gained 5.5%, which took the trading range above the 3-day high of $7.68 on volume of 14.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

4 Big Stocks on Traders' Radars
at The Street - Mon May 05, 1:55PM CDT
Here's a look at how to trade some of the most active stocks on the market today.

Most active Nasdaq-traded stocks
AP - Mon May 05, 12:22PM CDT
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at 1 p.m.:
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lucas Bols Wins Spirit Brand of the Year 2026

Updated Category News Views 104

Lucas Bols: A Legacy Crowned A 450-year-old legacy finally gets its due with the Lucas Bols Company snagging the "Spirit Brand of the Year" title from Wine Enthusiast. This ain’t just another pat on the back; it's a serious nod to a brand that’s been laying down the cocktail foundation long before some countries even existed. Across the past five centuries, they've...

Continue Reading
Asset Based Lending's $200M Securitization: A Power Move

Updated Category News Views 155

Well, folks, Asset Based Lending (ABL) in Jersey City just pulled a rabbit out of a challenging market hat, hammering out their heftiest securitization yet—a crisp $200 million deal. This isn't just pocket change, even for a seasoned player like ABL. Let's dive into what makes this move not just hefty in size, but a strategic punch in the current landscape of...

Continue Reading
Tax Strategies for Small Businesses Before Year-End

Updated Category News Views 106

Understanding the Importance of Year-Round Tax Planning Every small business owner dreads the tax season—like a thunderstorm on a picnic day. But here's a nugget from Paul Kersten, an Accounting and Tax whiz in Shawano, Wisconsin: don't wait until April to sort your taxes. By then, it's all receipts and regrets. Instead, consider tax planning as a year-long vigil. Why?...

Continue Reading
HLTH 2026: AI's Role in Couples Therapy Unveiled

Updated Category News Views 14

Testing AI's Place in the Therapy Room AI's getting more action in therapy sessions than it ever dreamed, and it’s high time we asked who benefits and who loses. Slotting in next to human therapists, AI like OurRitual’s Ora isn't about to steal the whole show, but it sure knows how to play a supporting role. At the HLTH 2026 conference, Dr. Orna Guralnik and OurRitual...

Continue Reading
HSG Laser Boosts EU Presence with Düsseldorf Showroom

Updated Category News Views 97

HSG Laser Makes a Bold Move in Europe When you're ripping off the band-aid and just diving into the hard truth, it's no small potatoes that HSG Laser has kicked open the doors to a shiny new showroom in Düsseldorf, Germany. This ain't just another brick in the wall—it's a sprawling 2,000 m² facility that marks a 20-year track record of tackling the European sector...

Continue Reading
Contract Signatures: The Black Hole of Business Time

Updated Category News Views 23

Why Do Signatures Take Ages to Nail Down? This is what’s driving us all a bit closer to the edge. Imagine you've slogged through drafting, approvals, haggling over terms, and you think you're on the home stretch—only to discover that getting signatures is a bottleneck more tangled than a bowl of spaghetti. ContractSafe just served up another pile of stats with their...

Continue Reading
Aethlon's Merger Moves: High Stakes and High Hopes

Updated Category News Views 32

Two-Step Merger Raises Eyebrows It's not every day you see a company like Aethlon Medical, Inc. (NASDAQ: AEMD) shake up its core operations with a bold merger move. On September 17, 2026, Aethlon signed off on a Plan of Merger and Reorganization with North Immunology, Inc.—a clear signal to investors that the winds of change are blowing strong. Implications of the...

Continue Reading
CytoSorbents Hits Financial Milestone in Q3 2026

Updated Category News Views 8

CytoSorbents' Financial Turnaround Imagine the smell of fresh opportunity wafting through CytoSorbents’ (NASDAQ:CTSO) corridors this quarter. The company just nudged into positive territory with its operating cash flow, which, let’s be honest, is like finding a nugget of gold amid last year’s rubble of losses. With $43,000 of positive operating cash flow in a world...

Continue Reading
Bit Digital Shifts Focus: Q3 2026 Sees Strategic Moves

Updated Category News Views 108

Bit Digital's Strategic Shakeup Ah, the digital gold rush is heating up again. Bit Digital, the outfit focused on Ethereum strategies and AI, dropped their financial results for Q3 2026. Picture a company at a strategic crossroads, shedding bitcoin mining baggage to grab hold of fresh opportunities in Ethereum staking and AI infrastructure. Bit Digital's earnings paint a...

Continue Reading
Keurig Dr Pepper's Bold $2B Offering: Strategic Shift

Updated Category News Views 112

Strategic Moves Behind KDP's $2 Billion Offering Walking through all this, Keurig Dr Pepper (NASDAQ:KDP) has set the stage for something big. Yeah, I'm talking about a hefty $2 billion underwritten public offering. It's one of those moves where you're either shaking your head in confusion or nodding in cautious approval. With the coffee behemoth taking this step, let's...

Continue Reading

Top 5 Most Recently Viewed Articles

New Immigration Rules Could Impact Benefits for Many Applicants

Updated Category News Views 141

Trump Administration's New Focus on Immigration Benefits The Trump administration has initiated significant changes in immigration policy, directing officials to closely investigate any expressions of perceived 'anti-American' sentiment among those applying for immigration benefits, including green cards and work permits. This directive poses the risk of denials for...

Continue Reading
Walton Isaacson Strengthens Leadership with New Appointments

Updated Category News Views 231

Walton Isaacson Expands Leadership Team Walton Isaacson (WI), a notable full-service advertising agency renowned for its innovative and inclusive strategies, has taken significant steps to enhance its leadership team and promote growth within the organization. The company recently announced the return of Christine Villanueva, Ph.D., as the Executive Vice President of...

Continue Reading
IM Cannabis Corp. Updates on Compliance and Acquisition Plans

Updated Category News Views 189

Corporate Updates from IM Cannabis Corp. IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) has announced significant corporate updates related to its recent developments within the medical cannabis sector. The company has operations in Germany and has been actively working to enhance its compliance and business strategies. Nasdaq Notification Update Recently, IM Cannabis...

Continue Reading
Investigation into Constellation Brands: What Investors Need to Know

Updated Category News Views 235

Ongoing Investigation into Constellation Brands Faruqi & Faruqi, LLP, a reputable national securities law firm, is currently delving into possible claims related to Constellation Brands, Inc. (NYSE: STZ). This investigation centers around losses experienced by investors and the implications of recent events surrounding the company's financial disclosures. Legal Options...

Continue Reading
Significant Delistings: Companies Removed from Nasdaq Stock Market

Updated Category News Views 1881

Key Delistings from the Nasdaq Stock Market In the world of finance, stock movements can greatly affect both investors and companies. Recently, there have been some important decisions regarding the delisting of various companies from the Nasdaq Stock Market. These changes are essential to understanding the current market landscape and the potential impact on...

Continue Reading